A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
New research suggests GLP-1 medications like semaglutide and tirzepatide don't just suppress appetite. They may actually rewire how the brain assigns value to high-calorie, rewarding foods. Here's what that means for patients considering or currently taking these drugs.
Novo Nordisk has raised its financial guidance after the oral Wegovy pill got off to a faster-than-expected sales start. For patients, this signals a major shift in how GLP-1 treatment could be accessed. Here is what you need to know before asking your doctor about the pill form.
Novo Nordisk's oral semaglutide pill is selling far beyond early expectations, pushing the company's stock up sharply. For patients weighing GLP-1 options, this development raises real questions about access, cost, and whether a pill might work as well as the weekly injection. Here's what you need to know.
Novo Nordisk is pushing forward with an oral version of Wegovy (semaglutide), and early sales momentum is already shifting the company's forecasts. If you're considering GLP-1 therapy or looking for alternatives to weekly injections, here's what this development means for you practically.
GLP-1 medications slow digestion, which can change how your body absorbs other oral drugs. This article explains which medications are most at risk for interactions, what symptoms to watch for, and what to discuss with your prescriber before starting treatment.
An oral form of semaglutide is now available, giving people a needle-free option for managing type 2 diabetes and potentially weight loss. This guide covers who qualifies, how the pill compares to injectable versions, what to expect on cost, and the practical steps to getting a prescription.
"Ozempic hands" has become a widely discussed side effect linked to GLP-1 medications like semaglutide and tirzepatide. This article explains the real science behind the phenomenon, who is most at risk, and practical steps you can take to protect your skin and overall appearance during weight loss.
A new announcement promises GLP-1 weight-loss medications at just $50 per month for Medicare patients. This could dramatically shift access for millions of older and lower-income Americans. Here is what the proposal means, what questions remain, and how to prepare.
